FY 2025 report
Constance Care nie prowadzi już działalności operacyjnej — przychody spadły do zera w 2025 r. (z 1,45 mln zł w 2023 r.), a jedyna aktywność spółki to narastanie odsetek na przeterminowanym długu
Sentiment
Cautious
No guidance change
CCR
FY 2025 report
Revenue
0 PLN
▼
-100% YoY
—
Net income
-1,869,302 PLN
▲
+63.2% YoY
—
EBITDA
-74,280 PLN
▲
+97.6% YoY
—
FCF
-1,780,317 PLN
▲
+7.6% YoY
—
Summary
Investment thesis
- Kapitał własny jest głęboko ujemny (-4,49 mln zł) i pogłębia się drugi rok z rzędu; spełnione są przesłanki art. 397 KSH obligujące do zwołania WZ w sprawie dalszego istnienia spółki
- 100% zadłużenia finansowego spółki (15,14 mln zł) jest sklasyfikowane jako przeterminowane, z czego prawie 5,9 mln zł to już same naliczone i niezapłacone odsetki bankowe
- Jedynym realnym aktywem jest nieruchomość w Kierszku (9,06 mln zł, 72% bilansu) wyceniona operatem sprzed pięciu lat, obciążona hipoteką do 13,87 mln zł na rzecz banku finansującego
- Cała 'strategia naprawy 2026-2028' zależy od wejścia bliżej nieokreślonego inwestora strategicznego oraz transferu działalności medycznej ze spółki CNR — żadne z tych zdarzeń nie jest jeszcze prawnie wiążące, a wcześniejsza próba układu restrukturyzacyjnego została prawomocnie odrzucona przez sąd
Read the full analysis
Financial data is open to everyone. The full analysis — management verdict, commentary, risks, and the full narrative — is available after you sign up or log in.
Financials
BETA
CCR · FY 2025
| Metric | FY 2025 | FY 2024 | Δ YoY | Value type | Segment | Conf. |
|---|---|---|---|---|---|---|
| Revenue | 0 | 84,264 | −100% | reported | — | 1.00 |
| EBITDA | -74,280 | -3,120,440 | +97.6% | reported | — | 0.90 |
| EBIT | -146,517 | -3,202,924 | +95.4% | reported | — | 1.00 |
| EBT | -1,869,302 | -5,081,312 | +63.2% | reported | — | 1.00 |
| Net income | -1,869,302 | -5,081,312 | +63.2% | reported | — | 1.00 |
| EPS (basic) | -2.38 | — | — | reported | — | 0.70 |
| D&A | 72,237 | 82,484 | −12.4% | reported | — | 1.00 |
| Interest expense | 1,722,785 | 1,859,903 | −7.4% | reported | — | 1.00 |
| Shares (basic) (units) | 785,620 | — | — | reported | — | 1.00 |
| Cash | 1,168 | 1,000 | +16.8% | reported | — | 1.00 |
| Total debt | 15,141,834 | 13,361,349 | +13.3% | reported | — | 1.00 |
| Net debt | 15,140,665 | 13,360,348 | +13.3% | derived | — | 1.00 |
| Equity | -4,492,545 | -2,623,244 | −71.3% | reported | — | 1.00 |
| Total assets | 12,534,050 | 12,624,463 | −0.7% | reported | — | 1.00 |
| Working capital | -2,785,011 | -2,549,185 | −9.3% | reported | — | 1.00 |
| Current assets | 7,827 | 8,726 | −10.3% | reported | — | 1.00 |
| Current liabilities | 2,792,839 | 2,557,911 | +9.2% | reported | — | 1.00 |
| Goodwill | 0 | 0 | — | reported | — | 1.00 |
| CFO | -1,780,317 | -1,927,034 | +7.6% | reported | — | 1.00 |
| CapEx | 0 | 0 | — | reported | — | 1.00 |
| FCF | -1,780,317 | -1,927,034 | +7.6% | reported | — | 1.00 |
| Current ratio | 0x | 0x | −0x | reported | — | 1.00 |
| Quick ratio | 0x | — | — | reported | — | 1.00 |
| Cash ratio | 0x | 0x | +0x | reported | — | 1.00 |
| Interest coverage | -0.09x | -1.72x | +1.64x | reported | — | 1.00 |
| Debt / assets | 1.21x | 1.06x | +0.15x | reported | — | 1.00 |
| Revenue growth (YoY) | -100% | -94.2% | — | reported | — | 1.00 |
| EBIT growth (YoY) | 95.43% | — | — | reported | — | 1.00 |
| Net income growth (YoY) | 63.21% | -217.66% | — | reported | — | 1.00 |
FY 2025 · Δ YoY
Revenue
0
−100%
0
−100%
- FY 2024
- 84,264
EBITDA
-74,280
+97.6%
-74,280
+97.6%
- FY 2024
- -3,120,440
EBIT
-146,517
+95.4%
-146,517
+95.4%
- FY 2024
- -3,202,924
EBT
-1,869,302
+63.2%
-1,869,302
+63.2%
- FY 2024
- -5,081,312
Net income
-1,869,302
+63.2%
-1,869,302
+63.2%
- FY 2024
- -5,081,312
EPS (basic)
-2.38
—
-2.38
—
- FY 2024
- —
D&A
72,237
−12.4%
72,237
−12.4%
- FY 2024
- 82,484
Interest expense
1,722,785
−7.4%
1,722,785
−7.4%
- FY 2024
- 1,859,903
Shares (basic)
(units)
785,620
—
785,620
—
- FY 2024
- —
Cash
1,168
+16.8%
1,168
+16.8%
- FY 2024
- 1,000
Total debt
15,141,834
+13.3%
15,141,834
+13.3%
- FY 2024
- 13,361,349
Net debt
15,140,665
+13.3%
15,140,665
+13.3%
- FY 2024
- 13,360,348
Equity
-4,492,545
−71.3%
-4,492,545
−71.3%
- FY 2024
- -2,623,244
Total assets
12,534,050
−0.7%
12,534,050
−0.7%
- FY 2024
- 12,624,463
Working capital
-2,785,011
−9.3%
-2,785,011
−9.3%
- FY 2024
- -2,549,185
Current assets
7,827
−10.3%
7,827
−10.3%
- FY 2024
- 8,726
Current liabilities
2,792,839
+9.2%
2,792,839
+9.2%
- FY 2024
- 2,557,911
Goodwill
0
—
0
—
- FY 2024
- 0
CFO
-1,780,317
+7.6%
-1,780,317
+7.6%
- FY 2024
- -1,927,034
CapEx
0
—
0
—
- FY 2024
- 0
FCF
-1,780,317
+7.6%
-1,780,317
+7.6%
- FY 2024
- -1,927,034
Current ratio
0x
−0x
0x
−0x
- FY 2024
- 0x
Quick ratio
0x
—
0x
—
- FY 2024
- —
Cash ratio
0x
+0x
0x
+0x
- FY 2024
- 0x
Interest coverage
-0.09x
+1.64x
-0.09x
+1.64x
- FY 2024
- -1.72x
Debt / assets
1.21x
+0.15x
1.21x
+0.15x
- FY 2024
- 1.06x
Revenue growth (YoY)
-100%
—
-100%
—
- FY 2024
- -94.2%
EBIT growth (YoY)
95.43%
—
95.43%
—
- FY 2024
- —
Net income growth (YoY)
63.21%
—
63.21%
—
- FY 2024
- -217.66%